• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pancreatic cancer.

作者信息

Hidalgo Manuel

机构信息

Centro Nacional de Investigaciones Oncológicas and Hospital de Madrid, Madrid.

出版信息

N Engl J Med. 2010 Apr 29;362(17):1605-17. doi: 10.1056/NEJMra0901557.

DOI:10.1056/NEJMra0901557
PMID:20427809
Abstract
摘要

相似文献

1
Pancreatic cancer.胰腺癌
N Engl J Med. 2010 Apr 29;362(17):1605-17. doi: 10.1056/NEJMra0901557.
2
[Diagnosis of and therapy for pancreatic neoplasms].[胰腺肿瘤的诊断与治疗]
Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):818-21. doi: 10.2169/naika.96.818.
3
Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胰腺腺癌：ESMO-ESDO诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii33-40. doi: 10.1093/annonc/mds224.
4
Pancreatic cancer: new studies, new treatments. "Periodontal disease,", "gemcitabine" and "adjuvant therapy" are the new buzzwords.胰腺癌：新研究，新疗法。“牙周病”“吉西他滨”和“辅助治疗”成为了新的热门词汇。
Duke Med Health News. 2007 Jun;13(6):8-9.
5
Management of locally advanced adenocarcinoma of the pancreas.局部晚期胰腺癌的管理
Hematol Oncol Clin North Am. 2002 Feb;16(1):95-103. doi: 10.1016/s0889-8588(01)00009-0.
6
Current treatment options for pancreatic carcinoma.胰腺癌的当前治疗选择。
Curr Oncol Rep. 2011 Jun;13(3):195-205. doi: 10.1007/s11912-011-0164-1.
7
[Concurrent chemoradiation therapy with gemcitabine for advanced or relapsed pancreatic tumors].吉西他滨同步放化疗治疗晚期或复发性胰腺肿瘤
Nihon Rinsho. 2006 Jan;64 Suppl 1:248-53.
8
Efficacy of gemcitabine for locally advanced pancreatic cancer: comparison with 5-fluorouracil-based chemoradiotherapy.吉西他滨治疗局部晚期胰腺癌的疗效：与基于5-氟尿嘧啶的放化疗对比
Chemotherapy. 2008;54(4):302-8. doi: 10.1159/000151226. Epub 2008 Aug 8.
9
[New horizon of the treatment of pancreatic cancer].[胰腺癌治疗的新视野]
Nihon Shokakibyo Gakkai Zasshi. 2004 Dec;101(12):1281-7.
10
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.SWOG S1505 研究的手术结果：吉西他滨/白蛋白紫杉醇对比改良 FOLFIRINOX 用于可切除胰腺导管腺癌围手术期治疗的随机临床试验。
Ann Surg. 2020 Sep 1;272(3):481-486. doi: 10.1097/SLA.0000000000004155.

引用本文的文献

1
High Score of ELST-Blue in Endoscopic Ultrasonography Strain Elastography May Provide a High Risk Group of Early Chronic Pancreatitis with the Reduction of Apolipoprotein A2-i Index.内镜超声弹性成像中ELST-Blue高分可能通过降低载脂蛋白A2-i指数提供早期慢性胰腺炎的高危组。
DEN Open. 2025 Aug 29;6(1):e70191. doi: 10.1002/deo2.70191. eCollection 2026 Apr.
2
Overexpression of Nuclear Factor of Activated T-cells (NFAT) Transcription Factors Drives Chemoresistance and Poor Outcomes in Pancreatic Cancer.活化T细胞核因子（NFAT）转录因子的过表达驱动胰腺癌的化疗耐药性并导致不良预后。
Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18186-9.
3
Advancements in Radiomics-Based AI for Pancreatic Ductal Adenocarcinoma.
基于放射组学的人工智能在胰腺导管腺癌中的进展。
Bioengineering (Basel). 2025 Aug 6;12(8):849. doi: 10.3390/bioengineering12080849.
4
Prognostic implications of venous invasion in pancreatic cancer following radical surgical resection: a pathological perspective.根治性手术切除后胰腺癌静脉侵犯的预后意义：病理学视角
Front Med (Lausanne). 2025 Jul 23;12:1613153. doi: 10.3389/fmed.2025.1613153. eCollection 2025.
5
The Incidence, Mortality, and Survival Trends of Pancreatic Cancer in Kazakhstan: Data from the National Electronic Registry of Oncological Patients (2014-2023).哈萨克斯坦胰腺癌的发病率、死亡率和生存趋势：来自国家肿瘤患者电子登记处的数据（2014 - 2023年）
Cancers (Basel). 2025 Jul 8;17(14):2277. doi: 10.3390/cancers17142277.
6
Early vs Conventional Oral Feeding after Pancreaticoduodenectomy: A Prospective Observational Study.胰十二指肠切除术后早期与传统经口喂养：一项前瞻性观察研究。
Euroasian J Hepatogastroenterol. 2025 Jan-Jun;15(1):29-33. doi: 10.5005/jp-journals-10018-1465. Epub 2025 Jun 18.
7
PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer.过氧化物酶体增殖物激活受体δ（PPARδ）协调胰腺癌对微环境信号的促转移代谢反应。
Cancer Res. 2025 Sep 2;85(17):3275-3291. doi: 10.1158/0008-5472.CAN-24-3475.
8
Nanomaterial-assisted pancreatic cancer theranostics.纳米材料辅助的胰腺癌诊疗
Regen Biomater. 2025 Jun 11;12:rbaf054. doi: 10.1093/rb/rbaf054. eCollection 2025.
9
Atypical Presentation of Pancreatic Cancer Mimicking IgG4-Related Disease.酷似IgG4相关疾病的胰腺癌非典型表现
Cureus. 2025 Jun 12;17(6):e85876. doi: 10.7759/cureus.85876. eCollection 2025 Jun.
10
Safety and Efficacy of Radiofrequency Ablation in Management of Various Pancreatic Neoplasms.射频消融术治疗各种胰腺肿瘤的安全性和有效性
J Clin Med. 2025 Jun 4;14(11):3958. doi: 10.3390/jcm14113958.